Vanguard Capital Management’s Rani Therapeutics RANI Stock Holding History
Bought
Maintained
Sold
Other funds holding RANI
AIC
SL
Vanguard Capital Management's RANI Position: Q3 2026 in Review
Vanguard Capital Management increased its Rani Therapeutics (RANI) stake by 0.08% in Q3 2026, buying an estimated $2.77K and bringing the position to 4,566,458 shares worth $3.61M. The position accounts for ﹤0.01% of the portfolio, ranked #3186.
Vanguard Capital Management first reported a position in RANI in Q1 2026 and has held it in 3 quarters since. 68 funds tracked by Wall St. Rank hold RANI as of Q3 2026.
- Vanguard Capital Management held 4,566,458 shares of Rani Therapeutics worth $3.61M as of Q3 2026.
- Vanguard Capital Management bought 3,473 Rani Therapeutics shares in Q3 2026, an estimated $2.77K.
- Rani Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3186 holding.
- Vanguard Capital Management first reported a position in Rani Therapeutics in Q1 2026 and has held it in 3 quarters since.
- 68 funds tracked by Wall St. Rank held Rani Therapeutics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.